PMI Labs uses the quantitative cytology technology, developed by Perceptronix Medical Inc, to provide new, highly informative early cancer detection tests. The technology that PMI Labs uses include: :
ClearCyte, Quantitative Pathology Systems
ClearSign
ClearVu and ClearVu Elite
ClearPath
Clear2C, Quantitative DNA Staining Kit
|